New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
08:38 EDTIMPVImperva sell-off overdone, says Sterne Agee
After Imperva expanded its 2014 revenue guidance, Sterne Agee expects the top end of the guidance to reach 20% in 2015. The firm expects the company's sales execution issues to be resolved, and it keeps a Buy rating on the shares.
News For IMPV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
08:35 EDTIMPVUnited computers said to be breached by hackers, Bloomberg reports
United Airlines (UAL) detected a breach of its computer systems in May or early June, reported Bloomberg, citing several people familiar with an investigation into the matter. The cyberattack on United has been linked to the China-backed hackers said to be responsible for several other large incursions, including thefts of data from the U.S. Office of Personnel Management and health insurer Anthem (ANTM), according to several of the people who talked to Bloomberg. Publicly traded companies in the cybersecurity space include Barracuda (CUDA), Check Point (CHKP), F5 Networks (FFIV), FireEye (FEYE), Fortinet (FTNT), Imperva (IMPV), Palo Alto (PANW), Proofpoint (PFPT), Qualys (QLYS) and Symantec (SYMC). Reference Link
July 27, 2015
07:16 EDTIMPVImperva announces agreement with Raytheon Websense
Imperva (IMPV) and Raytheon Websense, a joint venture of Raytheon (RTN) and Vista Equity Partners announced an agreement to facilitate safe and productive use of cloud apps for organizations of all sizes. The technology licensing and joint marketing agreement enables Raytheon Websense to embed the Imperva Skyfence Cloud App Catalog into its web security gateway products and also certifies joint interoperability to make it easier for customers to deploy and integrate the solutions.
July 17, 2015
14:37 EDTIMPVUCLA Health says 4.5M individuals' data possibly exposed in cyber attack
Subscribe for More Information
07:31 EDTIMPVImperva Q2 results should top consensus expectations, says Stephens
Stephens said it remains convinced after speaking with partners that Imperva is well positioned for "strong" organic growth and the firm expects the company's Q2 results to beat consensus expectations given the continued strength of Incapsula and better sales execution. The firm reiterates its Overweight rating and $75 price target on Imperva shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use